CWA Asset Management Group’s Cognition Therapeutics CGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.4K Sell
23,000
-2,250
-9% -$2.66K ﹤0.01% 703
2026
Q1
$19.2K Hold
25,250
﹤0.01% 664
2025
Q4
$34.1K Hold
25,250
﹤0.01% 636
2025
Q3
$34.1K Buy
+25,250
New +$34.4K ﹤0.01% 654

Other funds holding CGTX

CWA Asset Management Group's CGTX Position: Q2 2026 in Review

CWA Asset Management Group reduced its Cognition Therapeutics (CGTX) stake by 8.9% in Q2 2026, selling an estimated $2.66K and leaving 23,000 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #703.

CWA Asset Management Group first reported a position in CGTX in Q3 2025 and has held it in 4 quarters since. The position peaked at $34.1K in Q4 2025. 6 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • CWA Asset Management Group held 23,000 shares of Cognition Therapeutics worth $26.4K as of Q2 2026.
  • CWA Asset Management Group sold 2,250 Cognition Therapeutics shares in Q2 2026, an estimated $2.66K.
  • Cognition Therapeutics made up ﹤0.01% of CWA Asset Management Group's portfolio in Q2 2026, its #703 holding.
  • CWA Asset Management Group first reported a position in Cognition Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • CWA Asset Management Group's Cognition Therapeutics position peaked at $34.1K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.